E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects
Shailza Sharma(Medical University of South Carolina), Carol Feghali‐Bostwick(Pulmonary and Allergy Associates)
Cited by 21
Related Papers
Insulin-Like Growth Factor-II Is Increased in Systemic Sclerosis-Associated Pulmonary Fibrosis and Contributes to the Fibrotic Process via Jun N-Terminal Kinase- and Phosphatidylinositol-3 Kinase-Dependent Pathways
|American Journal Of Pathology|2008|52
Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions
|PLoS ONE|2019|49
Elucidating the cellular mechanism for E2-induced dermal fibrosis
|Arthritis Research & Therapy|2021|17